A Friday rally still left the major indexes significantly lower over the past five days of trading.
There wasn’t much good news to which to credit Friday’s move. U.S. industrial production improved less than expected in May, up 0.2% versus estimates for 0.4%; manufacturing actually declined by 0.1%. Wells Fargo economists Tim Quinlan and Shannon Seery defend the release as “actually a decent report,” however, noting that an upward revision to April’s number (+1.4% from +1.1%) puts May’s level of output slightly above expectations.
Edward Moya, senior market strategist at currency data provider OANDA, says that yesterday’s selloff might have been overdone. This quarter’s “quadruple witching” event – the simultaneous expiration of stock and stock-index futures and options – “may have accelerated the selling pressure leading up to today,” he says.
U.S. equities remained faithful to their 2022 narrative, with rate-sensitive stocks recovering most briskly as the 10-year Treasury yield cooled to as low as 3.19%. Communication services (+1.4%) and technology (+0.9%) shares were among the leaders; Charter Communications (CHTR, +6.4%) rebounded somewhat from yesterday’s gashing, with T-Mobile US (TMUS, +2.7%) and Salesforce.com (CRM, +2.1%) among Friday’s noteworthy winners.
The energy sector (-5.5%) was pummeled again, however, as U.S. crude oil prices sank (by 6.8% to $109.56 per barrel) as investors weighed both a possible downturn in demand amid global recessionary fears and the potential for higher supplies as U.S. production ramps up.
The end result was a nice 1.4% snap-back (to 10,798) for the Nasdaq Composite, which nonetheless finished the week with a 4.8% decline. The S&P 500 (+0.2% to 3,674) modestly improved to close the week down 5.8%, while the Dow Jones Industrial Average let its lead slip away and lost 0.1% to 29,888, ending the five-day period off 4.8%.
Other news in the stock market today:
- The small-cap Russell 2000 was bid 1.0% higher to 1,665.
- Gold futures fell 0.5% to settle at $1,840.60 an ounce.
- Bitcoin finished its week with a 1.6% decline to $20,512.15. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m.)
- Seagen (SGEN) jumped 12.7% amid buzz that blue-chip pharmaceutical firm Merck (MRK, -0.7%) is considering buying the biotech. Citing people familiar with them atter, a report in The Wall Street Journal suggested talks have been going on for awhile, but regulatory concerns exist. The acquisition would reportedly help the Dow Jones stock boost its portfolio of cancer treatments, which is currently led by blockbuster drug Keytruda.
- The AZEK Company (AZEK) gained 6.2% after BofA Global Research analyst Rafe Jadrosich upgraded the building products manufacturer to Buy from Hold. The bullish note came in the wake of AZEK’s analyst day, where the company forecast average annual revenue growth of 10% through 2027. Plus,”Azek is now trading roughly in-line with the building product group despite a significant material conversion opportunity in composite decking,” says Jadrosich. “In the last down cycle, decking only declined 20%. We would anticipate the composite decking companies to outperform the overall market given the acceleration of the conversion trend over the last two years.”
Accept the Volatility (And Profit During It)
There’s no gussying it up: This was a gut-wrenching week for most anyone with a stake in the market. And while strategists largely remain optimistic about stocks’ long-term prospects, investors might need to gird themselves for more of the tumultuous same over the coming months.
“Volatility and a bearish sentiment seem to have descended permanently on the US market for quite some time,” says Kunal Sawhney, CEO of Australian research firm Kalkine Group. “Inflation, impending recession, global economic slowdown and other macroeconomic fallouts of the Russia-Ukraine crisis have weighed heavily on investors. Hence, invariably, the U.S. stock market has become unsettled with a different outcome every day. If indexes end higher on one day, they drift lower the next.”
But you don’t have to silo yourself to one or two sectors.
UBS recently highlighted 43 stocks from across the market that look like attractive ways to profit during the market’s carnage. UBS focused on stocks where its analysts have “a truly differentiated view vs. the consensus, and where we have interesting or proprietary data sources.” If you’re a nimble investor looking to not just protect yourself, but generate a little alpha amid the chaos, read on.